- The University of Kansas Cancer Center Kansas City Vascular Symposium A Case-Based Update for Primary Care 2022
- + Include: 25 videos + 1 pdf, size: 1.38 GB
- + Target Audience: cardiologist, primary care physican
+ Information:
OBJECTIVES
- Describe advances in medical therapy for vascular disease
- Utilize innovative technologies and treatments
- Identify current evidence-based interventions for lower extremity arterial disease in the diabetic foot
- Discuss current management of neurovascular disease
- Identify treatment options for venous disease
DISCLOSURE STATEMENTS
Speakers:
- Michael Abraham, MD, Adam Alli, MD, Kamal Gupta, MD, Aaron M. Rohr, MD, and Axel Thors, DO, Assistant Professor have no relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
- Kamal Gupta, MD has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: renal denervation and other technologies are not yet approved in the US
- Planners and other Administrative Support:
- Monya Floyd, BA, Kirk Hance, MD, Nancy Grable, MSN, Kamal Gupta, MD, Axel Thors, DO, Assistant Professor, Cait Mestagh, BA, Angela West, RN, Alan Reeves, MD, Amy Mehaffey, RN, Jenny Cho, MD, Assistant Professor of Vascular Surgery, Kaitlyn Polley, BSN, Elizabeth Hart, RN and Brandon Custer, MD, Assistant Professor, Department of Radiology Residents/Fellows have no relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.
- Adam Alli, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Sirtex Medical – Speaking – Relationship Has Not Ended
- Penumbra – Speaking – Relationship Has Not Ended
+ Topics:
- Bronchure.pdf
- Session 1 Congenital Vascular Malformations Cosmetic to Life-Threatening.mp4
- Session 1 Panel discussion.mp4
- Session 1 Spider Veins Now You See Them, Now You Don’t.mp4
- Session 1 Swelling of the Legs.Is it from Venous Disease.mp4
- Session 1 Varicose Veins Evaluation and Treatment.mp4
- Session 1 Venous Ulcer Recognition and Treatment.mp4
- Session 2 Early Identification and Triage of the Stroke Patient.mp4
- Session 2 Innovative Management in Technology of Stroke.mp4
- Session 2 Intracerebral Aneurysms A Primer for the General Practitioner.mp4
- Session 2 Pseudotumor Cerebri and Headaches Stenting the Pipes.mp4
- Session 3 Fenestrated Endografts Treatment for Complex Abdominal Aortic and Thoracoabdominal Aneurysms.mp4
- Session 3 Innovations in the Treatment of Hypertension.mp4
- Session 3 Panel discussion.mp4
- Session 3 Radiation Exposure for the Primary Care Patient Why This Cannot Be Ignored.mp4
- Session 3 Trans Carotid Artery Revascularization (TCAR) Treatment of High-Risk Carotid Occlusive Disease.mp4
- Session 4 Complex Soft Tissue Reconstructions of the Lower Extremity.mp4
- Session 4 Diabetic Foot Small Vessel Disease Advancements in Vessel Reconstruction.mp4
- Session 4 Drug Eluting Balloons and Stents for PAD Are They Safe.mp4
- Session 4 No Option Patient with Limb Ischemia Are There Options.mp4
- Session 4 Panel discussion.mp4
- Session 5 Anticoagulation in Peripheral Artery Disease Is There a Role.mp4
- Session 5 Deep Venous Thrombosis How Long to Anticoagulate.mp4
- Session 5 Is It Time to Use PCSK9 Inhibitors in PAD.mp4
- Session 5 Lipoprotein A in Cardiovascular Disease.mp4
- Session 5 Panel discussion.mp4
